Previous studies of our group have demonstrated that Gal-3 pharmacological inhibition with MCP prevented cardiac dysfunction, fibrosis and inflammation in several pathophysiological conditions such as hyperaldosteronism5,8, obesity, hypertension6 or aortic stenosis. The gene discussed is LGALS3; the disease is aortic stenosis.